400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Protein Tyrosine Kinase/RTK / Syk / 6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one benzenesulfonate
CAS No.: 841290-81-1
Synonyms: Tamatinib Benzenesulfonate;Tamatinib,
R406 benzenesulfonate is a selective inhibitor of Syk with IC50 of 41 nM.
生物活性
靶点 | Syk IC50:41nM |
实验方案
技术信息
CAS号 | 841290-81-1 | 储存条件 |
|
|||||||||||||
分子式 | C28H29FN6O8S | 运输 | 蓝冰 | |||||||||||||
分子量 | 628.63 | 别名 | Tamatinib Benzenesulfonate;Tamatinib, | |||||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
AB5 | 0-2.5 μM | Apoptosis Assay | 48 h | induces apoptosis | 23398911 |
AB5 | 0-2.5 μM | Growth Inhibition Assay | 48 h | induces cell cycle arrest | 23398911 |
AMO-1 | 1 μM | Function Assay | 3 h | reduces migration | 26251761 |
CFSE-CD11b+ | 0.0625-1 μM | Growth Inhibition Assay | 8 d | blocks proliferation of GVHD-derived CD4+ T cells and CD11b+ cells | 24679982 |
CFSE-CD4+ T | 0.0625-1 μM | Growth Inhibition Assay | 4 d | blocks proliferation of GVHD-derived CD4+ T cells and CD11b+ cells | 24679982 |
DHL10 | 0/1/4 μM | Apoptosis Assay | 96 h | induces apoptosis dose dependently | 18006696 |
DHL4 | 0/1/4 μM | Apoptosis Assay | 96 h | induces apoptosis dose dependently | 18006696 |
DHL4 | 4 μM | Apoptosis Assay | 96 h | induces cleavage of caspases 9 and 3, but not caspase 8 | 18006696 |
DHL4 | 4 μM | Function Assay | 16 h | inhibits tonic BLNK tyrosine phosphorylation | 18006696 |
DHL6 | 0/1/4 μM | Apoptosis Assay | 96 h | induces apoptosis dose dependently | 18006696 |
DHL6 | 4 μM | Apoptosis Assay | 96 h | induces cleavage of caspases 9 and 3, but not caspase 8 | 18006696 |
DHL6 | 4 μM | Function Assay | 16 h | inhibits tonic BLNK tyrosine phosphorylation | 18006696 |
DHL8 | 0/1/4 μM | Apoptosis Assay | 96 h | induces apoptosis dose dependently | 18006696 |
DoHH2 | 0/3/10 μM | Apoptosis Assay | 48 h | induces cell death significantly | 20875408 |
HMECs | 0-10 μM | Function Assay | 20 min | inhibits VEGF-stimulated release of NO | 24329544 |
JB7 | 0-2.5 μM | Apoptosis Assay | 48 h | induces apoptosis | 23398911 |
JB7 | 0-2.5 μM | Growth Inhibition Assay | 48 h | induces cell cycle arrest | 23398911 |
Jeko-1 | - | Growth Inhibition Assay | 48 h | IC50=5.06826 μM | 25835755 |
Jeko-1 | 5 μM | Apoptosis Assay | 24 h | induces 25.1 ± 3.2 % apoptosis | 25835755 |
Jeko-1 | 0/3/10 μM | Apoptosis Assay | 48 h | induces cell death significantly | 20875408 |
LY1 | 0/1/4 μM | Apoptosis Assay | 96 h | induces apoptosis dose dependently | 18006696 |
LY10 | 0/1/4 μM | Apoptosis Assay | 96 h | induces apoptosis dose dependently | 18006696 |
LY10 | 4 μM | Function Assay | 16 h | inhibits tonic BLNK tyrosine phosphorylation | 18006696 |
LY18 | 0/1/4 μM | Apoptosis Assay | 96 h | induces apoptosis dose dependently | 18006696 |
LY18 | 4 μM | Function Assay | 16 h | inhibits tonic BLNK tyrosine phosphorylation | 18006696 |
LY3 | 0/1/4 μM | Apoptosis Assay | 96 h | induces apoptosis dose dependently | 18006696 |
LY3 | 4 μM | Apoptosis Assay | 96 h | induces cleavage of caspases 9 and 3, but not caspase 8 | 18006696 |
LY3 | 4 μM | Function Assay | 16 h | inhibits tonic BLNK tyrosine phosphorylation | 18006696 |
LY7 | 0/1/4 μM | Apoptosis Assay | 96 h | induces apoptosis dose dependently | 18006696 |
LY7 | 4 μM | Apoptosis Assay | 96 h | induces cleavage of caspases 9 and 3, but not caspase 8 | 18006696 |
LY7 | 4 μM | Function Assay | 16 h | inhibits tonic BLNK tyrosine phosphorylation | 18006696 |
Mino | - | Growth Inhibition Assay | 48 h | IC50=5.70854 μM | 25835755 |
PBMCs | 0-50 μM | Cell Viability Assay | 24 h | inhibits cell viability dose dependently | 25127862 |
PBMCs | 5 μM | Function Assay | 1 h | decreases the cell migration | 25127862 |
platelet | 1 μm | Function Assay | 5 min | inhibits FcγRIIA-mediated platelet aggregation | 21848694 |
platelet | 0.05/1/2.5 μM | Function Assay | 5 min | inhibits the signaling mechanisms downstream of FcγRIIA | 21848694 |
primary MCL | 2 µM | Apoptosis Assay | 24 h | increases significantly apoptosis | 25388373 |
Raji | 0/3/10 μM | Apoptosis Assay | 48 h | induces cell death significantly | 20875408 |
RL | 2.5/5 μM | Function Assay | 24/48 h | induces a potent decrease in MMP-9 mRNA expression | 21926965 |
RL | 1/2.5 μM | Function Assay | 24 h | reduces the activation of Akt and p70S6K | 21926965 |
U266 | 1 μM | Function Assay | 3 h | reduces migration | 26251761 |
Wsu-NHL | 0/1/4 μM | Apoptosis Assay | 96 h | induces apoptosis dose dependently | 18006696 |
Wsu-NHL | 4 μM | Function Assay | 16 h | inhibits tonic BLNK tyrosine phosphorylation | 18006696 |
靶点 | Description | IC50 |
---|---|---|
Syk | IC50:41nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网